USD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
$40.67B
Market Cap
31.39
P/E Ratio
4.57
EPS
$160.27
52 Week High
$96.03
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $3.6B |
| Total Revenue | $6.9B |
| Cost Of Revenue | $3.3B |
| Costof Goods And Services Sold | $3.3B |
| Operating Income | $1.5B |
| Selling General And Administrative | $1.7B |
| Research And Development | $455M |
| Operating Expenses | $2.2B |
| Investment Income Net | - |
| Net Interest Income | - |
| Interest Income | $50M |
| Interest Expense | $112M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $288M |
| Income Before Tax | $1.4B |
| Income Tax Expense | $132M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | - |
| Comprehensive Income Net Of Tax | - |
| Ebit | $1.5B |
| Ebitda | $1.8B |
| Net Income | $1.3B |
| Field | Value (USD) |
|---|---|
| Gross Profit | $3.6B |
| Total Revenue | $6.9B |
| Cost Of Revenue | $3.3B |
| Costof Goods And Services Sold | $3.3B |
| Operating Income | $1.5B |
| Selling General And Administrative | $1.7B |
| Research And Development | $455M |
| Operating Expenses | $2.2B |
| Investment Income Net | - |
| Net Interest Income | - |
| Interest Income | $50M |
| Interest Expense | $112M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $288M |
| Income Before Tax | $1.4B |
| Income Tax Expense | $132M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | - |
| Comprehensive Income Net Of Tax | - |
| Ebit | $1.5B |
| Ebitda | $1.8B |
| Net Income | $1.3B |
| Field | Value |
|---|---|
| Ex Dividend Date | 2026-01-06 |
| Declaration Date | 2025-11-19 |
| Record Date | 2026-01-06 |
| Payment Date | 2026-01-28 |
| Amount | 0.255 |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Agilent Technologies, Inc. is a leading American firm based in Santa Clara, California, that specializes in analytical instrumentation and life sciences solutions. The company is recognized for its innovative offerings that serve critical sectors such as scientific research, diagnostics, and quality control, establishing itself as an essential player in the global analytical market. Agilent's comprehensive portfolio, which includes state-of-the-art instruments and software, supports advancements in life sciences and applied chemistry. With a robust focus on innovation and a customer-first approach, Agilent is well-positioned to address the dynamic needs of its clients, making it an attractive investment prospect for institutional investors seeking growth in the evolving landscape of scientific innovation.